86 related articles for article (PubMed ID: 23658772)
1. Identification of bacterial protein O-oligosaccharyltransferases and their glycoprotein substrates.
Schulz BL; Jen FE; Power PM; Jones CE; Fox KL; Ku SC; Blanchfield JT; Jennings MP
PLoS One; 2013; 8(5):e62768. PubMed ID: 23658772
[TBL] [Abstract][Full Text] [Related]
2. Three-component systems represent a common pathway for extracytoplasmic addition of pentofuranose sugars into bacterial glycans.
Kelly SD; Duong NH; Nothof JT; Lowary TL; Whitfield C
Proc Natl Acad Sci U S A; 2024 May; 121(21):e2402554121. PubMed ID: 38748580
[TBL] [Abstract][Full Text] [Related]
3.
Fujinami D; Mizui A; Miyata A; Ito S
ACS Chem Biol; 2024 Apr; 19(4):992-998. PubMed ID: 38562012
[TBL] [Abstract][Full Text] [Related]
4. Insights into bacterial protein glycosylation in human microbiota.
Zhu F; Wu H
Sci China Life Sci; 2016 Jan; 59(1):11-8. PubMed ID: 26712033
[TBL] [Abstract][Full Text] [Related]
5. ProGlycProt V3.0: updated insights into prokaryotic glycoproteins and their glycosyltransferases.
Janhvi S; Saini S; Singh V; Sharma T; Rao A
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38153163
[TBL] [Abstract][Full Text] [Related]
6. CRISPRi-Mediated Silencing of
Lewis JM; Scott NE
J Proteome Res; 2023 Jun; 22(6):1762-1778. PubMed ID: 36995114
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia PglL enzymes are Serine preferring oligosaccharyltransferases which target conserved proteins across the Burkholderia genus.
Hayes AJ; Lewis JM; Davies MR; Scott NE
Commun Biol; 2021 Sep; 4(1):1045. PubMed ID: 34493791
[TBL] [Abstract][Full Text] [Related]
8. Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria.
Natarajan A; Jaroentomeechai T; Cabrera-Sánchez M; Mohammed JC; Cox EC; Young O; Shajahan A; Vilkhovoy M; Vadhin S; Varner JD; Azadi P; DeLisa MP
Nat Chem Biol; 2020 Oct; 16(10):1062-1070. PubMed ID: 32719555
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide O-antigens-bacterial glycans made to measure.
Whitfield C; Williams DM; Kelly SD
J Biol Chem; 2020 Jul; 295(31):10593-10609. PubMed ID: 32424042
[TBL] [Abstract][Full Text] [Related]
10. Glycoengineering bioconjugate vaccines, therapeutics, and diagnostics in E. coli.
Harding CM; Feldman MF
Glycobiology; 2019 Jul; 29(7):519-529. PubMed ID: 30989179
[TBL] [Abstract][Full Text] [Related]
11. A pathway-directed positive growth restoration assay to facilitate the discovery of lipid A and fatty acid biosynthesis inhibitors in Acinetobacter baumannii.
Richie DL; Wang L; Chan H; De Pascale G; Six DA; Wei JR; Dean CR
PLoS One; 2018; 13(3):e0193851. PubMed ID: 29505586
[TBL] [Abstract][Full Text] [Related]
12. The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.
Mubaiwa TD; Semchenko EA; Hartley-Tassell LE; Day CJ; Jennings MP; Seib KL
Pathog Dis; 2017 Jul; 75(5):. PubMed ID: 28633281
[TBL] [Abstract][Full Text] [Related]
13. Emerging facets of prokaryotic glycosylation.
Schäffer C; Messner P
FEMS Microbiol Rev; 2017 Jan; 41(1):49-91. PubMed ID: 27566466
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System.
Pan C; Sun P; Liu B; Liang H; Peng Z; Dong Y; Wang D; Liu X; Wang B; Zeng M; Wu J; Zhu L; Wang H
mBio; 2016 Apr; 7(2):e00443-16. PubMed ID: 27118590
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Acinetobacter: from the Cell Surface to Infinity and Beyond.
Weber BS; Harding CM; Feldman MF
J Bacteriol; 2015 Dec; 198(6):880-7. PubMed ID: 26712938
[TBL] [Abstract][Full Text] [Related]
16. Protein O-linked glycosylation in the plant pathogen Ralstonia solanacearum.
Elhenawy W; Scott NE; Tondo ML; Orellano EG; Foster LJ; Feldman MF
Glycobiology; 2016 Mar; 26(3):301-11. PubMed ID: 26531228
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a Unique Tetrasaccharide and Distinct Glycoproteome in the O-Linked Protein Glycosylation System of Neisseria elongata subsp. glycolytica.
Anonsen JH; Vik Å; Børud B; Viburiene R; Aas FE; Kidd SW; Aspholm M; Koomey M
J Bacteriol; 2016 Jan; 198(2):256-67. PubMed ID: 26483525
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii.
Eijkelkamp BA; Stroeher UH; Hassan KA; Paulsen IT; Brown MH
BMC Genomics; 2014 Nov; 15(1):1020. PubMed ID: 25422040
[TBL] [Abstract][Full Text] [Related]
19. Diversity within the O-linked protein glycosylation systems of acinetobacter species.
Scott NE; Kinsella RL; Edwards AV; Larsen MR; Dutta S; Saba J; Foster LJ; Feldman MF
Mol Cell Proteomics; 2014 Sep; 13(9):2354-70. PubMed ID: 24917611
[TBL] [Abstract][Full Text] [Related]
20. New insights into dissemination and variation of the health care-associated pathogen Acinetobacter baumannii from genomic analysis.
Wright MS; Haft DH; Harkins DM; Perez F; Hujer KM; Bajaksouzian S; Benard MF; Jacobs MR; Bonomo RA; Adams MD
mBio; 2014 Jan; 5(1):e00963-13. PubMed ID: 24449752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
